Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director |
13,313 | $34.5 | $459,299 | 0 (Direct) |
View |
| 2020-08-21 Sale |
2020-08-24 6:21 pm |
Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer |
25,000 | $18.29 | $457,240 | 282,810 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-20 Tax Withholding |
2021-02-23 6:05 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer |
35,672 | $18.79 | 242,499 (Direct) |
View |
| 2020-11-20 Tax Withholding |
2020-11-24 6:16 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer |
4,639 | $17.21 | 278,171 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director |
6,250 | $34.5 | 0 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-24 6:21 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K Chief Medical Officer |
4,646 | $18.22 | 282,810 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:17 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director |
38,766 | $0 | 45,016 (Direct) |
View |
| 2020-05-20 Tax Withholding |
2020-05-22 6:06 pm |
N/A N/A |
Theravance Biopharma Inc. | TBPH | HAUMANN BRETT K SVP Clin Dev & Chief Med Ofc |
4,212 | $26.67 | 312,456 (Direct) |
View |